A Case of Hydroxyurea-Intolerant Polycythemia Vera
Targeted Oncology This individual started with therapy with phlebotomy and aspirin. When we think about treating patients with polycythemia vera, we know that control of the hematocrit is a key cornerstone. And that should be a hematocrit of 45% or less. We know now ... |
from phlebotomy - Google News http://bit.ly/2rxqeOa
No comments:
Post a Comment